Blood Transfusion Diagnostics Market
Blood Transfusion Diagnostics Market by Product Type, By Application, By End-user & By Region - Global Market Insights 2025 to 2035
Analysis of Blood Transfusion Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT4720MR
- 23 Apr 2025
- Healthcare
- 170 Pages
- 30 Tables
- 79 Figures
- Forecast Value (2035): 8755.2 Mn
- CAGR (2035): 6.1%
Table of Content
- Preface
- Assumptions and Research Methodology
- Executive Summary: Global Market
- Market Overview
- Spend for Plasma Testing For Infectious Diseases (USD Million), by Plasma Fractionation Companies, 2025
- Global Market Analysis and Forecasts, by Product Type
- Instruments
- Kits & Reagents
- Global Market Analysis and Forecasts, by Application
- Blood Grouping
- Disease Screening
- Serological Disease Screening
- Molecular Disease Screening
- Global Market Analysis and Forecasts, by End-user
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Plasma Fractionation Companies
- Others
- Global Market Analysis and Forecasts, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Market Analysis and Forecast
- Europe Market Analysis and Forecast
- Asia Pacific Market Analysis and Forecast
- Latin America Market Analysis and Forecast
- Middle East & Africa Market Analysis and Forecast
- Company Profiles
- Grifols S.A.
- Immucor, Inc.
- Ortho Clinical Diagnostics
- Abbott
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- QUOTIENT LIMITED
- BAG Healthcare GmBH
- DiaSorin S.p.A.
- Hologic, Inc.
List Of Table
Table 01: Global Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 02: Global Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 03: Global Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 04: Global Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035
Table 05: Global Market Revenue (USD Million) Forecast, by Region, 2025 to 2035
Table 06: North America Market Revenue (USD Million) Forecast, by Country, 2025 to 2035
Table 07: North America Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 08: North America Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 09: North America Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 10: North America Market Revenue (USD Million) Forecast, by End User, 2025 to 2035
Table 11: Europe Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035
Table 12: Europe Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 13: Europe Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 14: Europe Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 15: Europe Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035
Table 16: Asia Pacific Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035
Table 17: Asia Pacific Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 18: Asia Pacific Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 19: Asia Pacific Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 20: Asia Pacific Market Revenue (USD Million) Forecast, by End User, 2025 to 2035
Table 21: Latin America Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035
Table 22: Latin America Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 23: Latin America Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 24: Latin America Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 25: Latin America Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035
Table 26: Middle East & Africa Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035
Table 27: Middle East & Africa Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035
Table 28: Middle East & Africa Market Revenue (USD Million) Forecast, by Application, 2025 to 2035
Table 29: Middle East & Africa Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035
Table 30: Middle East & Africa Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035
List Of Figures
Figure 01: Global Market Size (USD Million) Forecast, 2025 to 2035
Figure 02: Global Market Value Share, by Region (2018)
Figure 04: Global Market Value Share, by Application (2018)
Figure 03: Global Market Value Share, by Product Type (2018)
Figure 05: Global Market Value Share, by End-user (2018)
Figure 06: Global Market Value Share, by Product Type, 2025 and 2035
Figure 07: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Instruments, 2025 to 2035
Figure 08: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,
Figure 09: Global Market Attractiveness, by Product Type, 2025 to 2035
Figure 10: Global Market Value Share, by Application, 2025 and 2035
Figure 11: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2025 to 2035
Figure 12: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Disease Screening,
Figure 13: Global Market Attractiveness, by Application, 2025 to 2035
Figure 14: Global Market Value Share, by End-user, 2025 and 2035
Figure 15: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Hospitals, 2025 to 2035
Figure 16: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Blood Banks,
Figure 17: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2025 to 2035
Figure 18: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2025 to 2035
Figure 19: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Others, 2025 to 2035
Figure 20: Global Market Attractiveness, by End-user, 2025 to 2035
Figure 21: Global Market Value Share, by Region, 2025 and 2035
Figure 22: Global Market Attractiveness, by Region, 2025 to 2035
Figure 23: North America Market Value Share, by Country, 2025 and 2035
Figure 24: North America Market Attractiveness, by Country, 2025 to 2035
Figure 25: North America Market Value Share, by Product Type, 2025 and 2035
Figure 26: North America Market Attractiveness, by Product Type, 2025 to 2035
Figure 27: North America Market Value Share, by Application, 2025 and 2035
Figure 28: North America Market Attractiveness, by Application, 2025 to 2035
Figure 29: North America Market Value Share, by End-user, 2025 and 2035
Figure 30: North America Market Attractiveness, by End-user, 2025 to 2035
Figure 31: Europe Market Value Share, by Country/Sub-region, 2025 and 2035
Figure 32: Europe Market Attractiveness, by Country/Sub-region, 2025 to 2035
Figure 33: Europe Market Value Share, by Product Type, 2025 and 2035
Figure 34: Europe Market Attractiveness, by Product Type, 2025 to 2035
Figure 35: Europe Market Value Share, by Application, 2025 and 2035
Figure 36: Europe Market Attractiveness, by Application, 2025 to 2035
Figure 37: Europe Market Value Share, by End-user, 2025 and 2035
Figure 38: Europe Market Attractiveness, by End-user, 2025 to 2035
Figure 39: Asia Pacific Market Value Share, by Country/Sub-region, 2025 and 2035
Figure 40: Asia Pacific Market Attractiveness, by Country/Sub-region, 2025 to 2035
Figure 41: Asia Pacific Market Value Share, by Product Type, 2025 and 2035
Figure 42: Asia Pacific Market Attractiveness, by Product Type, 2025 to 2035
Figure 43: Asia Pacific Market Value Share, by Application, 2025 and 2035
Figure 44: Asia Pacific Market Attractiveness, by Application, 2025 to 2035
Figure 45: Asia Pacific Market Value Share, by End-user, 2025 and 2035
Figure 46: Asia Pacific Market Attractiveness, by End-user, 2025 to 2035
Figure 47: Latin America Market Value Share, by Country/Sub-region, 2020 and 2025
Figure 48: Latin America Market Attractiveness, by Country/Sub-Region, 2025 to 2035
Figure 49: Latin America Market Value Share, by Product Type, 2025 and 2035
Figure 50: Latin America Market Attractiveness, by Product Type, 2025 to 2035
Figure 51: Latin America Market Value Share, by Application, 2025 and 2035
Figure 52: Latin America Market Attractiveness, by Application, 2025 to 2035
Figure 53: Latin America Market Value Share, by End-user, 2025 and 2035
Figure 54: Latin America Market Attractiveness, by End-user, 2025 to 2035
Figure 55: Middle East & Africa Market Value Share, by Country/Sub-Region, 2025 and 2035
Figure 56: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2025 to 2035
Figure 57: Middle East & Africa Market Value Share, by Product Type, 2025 and 2035
Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2025 to 2035
Figure 59: Middle East & Africa Market Value Share, by Application, 2025 and 2035
Figure 60: Middle East & Africa Market Attractiveness, by Application, 2025 to 2035
Figure 61: Middle East & Africa Market Value Share, by End-user, 2025 and 2035
Figure 62: Middle East & Africa Market Attractiveness, by End-user, 2025 to 2035
Figure 63: Global Market Share (%) & Market Share Range (%), by Company, 2020 (Estimated)
Figure 64: Grifols S.A. Breakdown of Net Sales, by Business Segment, 2020
Figure 65: Grifols S.A. Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021
Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2020
Figure 67: DiaSorin S.p.A. Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021
Figure 68: Immucor, Inc., Breakdown of Net Sales, by Product Group, 2021
Figure 69: Immucor, Inc., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021
Figure 70: Abbott Breakdown of Revenue (USD Million), by Region, 2021
Figure 71: Abbott Revenue (USD Bilion) and Y-o-Y Growth (%), 2017 to 2021
Figure 72: Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2021
Figure 73: Bio-Rad Laboratories, Inc., Revenue (USD Billion) and Y-o-Y Growth (%), 2017 to 2021
Figure 74: Hologic, Inc., Breakdown of Net Sales, by Region, 2021
Figure 75: Hologic, Inc., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021
Figure 76: QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2021
Figure 77: QUOTIENT LIMITED, Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021
Figure 78: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2021
Figure 79: F. Hoffmann-La Roche Ltd., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021